| Goods |
INDIVIDUAL INVESTOR
Ruth Arnon
Summary
Overview
Number of Portfolio Companies
1
CB Rank (Investor)
138,264
Primary Job Title Professor of Immunology
Primary Organization
Weizmann Institute of Science Logo
Weizmann Institute of Science
Gender Female
Investor Type Individual/Angel
Ruth Arnon is an Israeli biochemist and codeveloper of the multiple sclerosis drug Copaxone. She is currently the Paul Ehrlich Professor of Immunology at the Weizmann Institute of Science, where she is researching anti-cancer and influenza vaccinations.
Personal Investments
Number of Investments
1
Ruth Arnon invested in Social Finance Israel on Aug 17, 2017. This investment - Grant - Social Finance Israel - was valued at $20M.
Announced Date
Organization Name
Lead Investor
Funding Round
Money Raised
Aug 17, 2017
Social Finance Israel Logo
Social Finance Israel
—
Grant - Social Finance Israel Logo
Grant - Social Finance Israel
|